We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

52 hedge funds and large institutions have $30.4M invested in Neos Therapeutics, Inc in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

29% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 14

8% more funds holding

Funds holding: 48 → 52 (+4)

15% less capital invested

Capital invested by funds: $35.9M → $30.4M (-$5.51M)

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
18
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
+$2.3M
2
CCI
Columbus Circle Investors
+$286K
3
Morgan Stanley
Morgan Stanley
New York
+$246K
4
State Street
State Street
Massachusetts
+$244K
5
UBS Group
UBS Group
Switzerland
+$232K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$2.23M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.19M
3
BFA
BlackRock Fund Advisors
California
-$1.13M
4
WSA
Wall Street Associates
California
-$983K
5
PI
Putnam Investments
Massachusetts
-$670K
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
1
Franklin Resources
California
$7.7M +$5.41K +800 +0.1%
DA
2
DSC Advisors
Illinois
$4.06M -$617K -91,122 -12%
Northern Trust
3
Northern Trust
Illinois
$2.81M +$2.3M +339,616 +242%
BFA
4
BlackRock Fund Advisors
California
$2.61M -$1.13M -167,255 -27%
Millennium Management
5
Millennium Management
New York
$1.73M -$25.9K -3,825 -1%
DM
6
Deerfield Management
New York
$1.34M – – –
BIT
7
BlackRock Institutional Trust
California
$1.19M +$214K +31,659 +18%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.09M -$1.19M -175,801 -48%
State Street
9
State Street
Massachusetts
$903K +$244K +36,058 +30%
PI
10
Putnam Investments
Massachusetts
$679K -$670K -98,962 -46%
UBS Group
11
UBS Group
Switzerland
$599K +$232K +34,279 +50%
Russell Investments Group
12
Russell Investments Group
United Kingdom
$545K +$590K +87,256 New
FPC
13
Falcon Point Capital
California
$501K +$111K +16,453 +24%
BCM
14
Bridgeway Capital Management
Texas
$468K – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$450K +$17.7K +2,613 +4%
BAMCO Inc
16
BAMCO Inc
New York
$412K +$60.9K +9,000 +15%
BIM
17
BlackRock Investment Management
Delaware
$300K – – –
CAM
18
Cormorant Asset Management
Massachusetts
$296K – – –
Morgan Stanley
19
Morgan Stanley
New York
$275K +$246K +36,305 +339%
TCIM
20
TIAA CREF Investment Management
New York
$261K -$3.31K -489 -1%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$256K +$79.9K +11,805 +37%
CCI
22
Columbus Circle Investors
$247K +$286K +42,304 New
DCM
23
DAFNA Capital Management
California
$227K – – –
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$166K -$5.41K -800 -3%
TA
25
Teachers Advisors
New York
$149K +$24.2K +3,572 +16%
1
2 3

NEOS Hedge Fund Activity: Q4 2016 in Review

52 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q4 2016, worth a combined $30.4M — down 15% from $35.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NEOS positions and 4 closed out — a net gain of 4 holders — while 18 added to existing stakes and 14 trimmed.

The largest buyer was Northern Trust, adding an estimated $2.3M. The largest seller was Perceptive Advisors, cutting an estimated $2.23M.

  • 52 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q4 2016, up from 48 in Q3 2016.
  • Funds reported $30.4M of Neos Therapeutics, Inc stock for Q4 2016, down 15% quarter-over-quarter.
  • 8 funds opened new Neos Therapeutics, Inc positions in Q4 2016 and 4 closed out, a net change of +4 holders.
  • The largest Neos Therapeutics, Inc buyer in Q4 2016 was Northern Trust, an estimated $2.3M added.
  • The largest Neos Therapeutics, Inc seller in Q4 2016 was Perceptive Advisors, an estimated $2.23M sold.

Based on aggregated 13F filings for Q4 2016.